Azintuxizumab vedotin (ABBV-838) is an antibody-drug conjugate (ADC) targeting a unique epitope of CD2 subset 1, a cell-surface glycoprotein expressed on multiple myeloma cells[1].
Molecular Weight:
(146.036 kDa)
Purity:
98.55
CAS Number:
[1826819-58-2]
Target:
Antibody-Drug Conjugates (ADCs)
Application Notes:
MCE Product type: ADC Related
* VAT and and shipping costs not included. Errors and price changes excepted